13-azaprostanoic acid has been researched along with prostaglandin h2 in 6 studies
| Studies (13-azaprostanoic acid) | Trials (13-azaprostanoic acid) | Recent Studies (post-2010) (13-azaprostanoic acid) | Studies (prostaglandin h2) | Trials (prostaglandin h2) | Recent Studies (post-2010) (prostaglandin h2) |
|---|---|---|---|---|---|
| 42 | 0 | 0 | 413 | 0 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brace, LD; Le Breton, GC; Venton, DL | 2 |
| Ghali, NI; Hung, SC; Le Breton, GC; Venton, DL | 1 |
| Le Breton, GC; Parise, LV; Venton, DL | 1 |
| Feinberg, H; Ho, T; Le Breton, GC; Lipowski, JP; Venton, DL; Wu, KK | 1 |
| Le Breton, GC; Rybicki, JP; Venton, DL | 1 |
6 other study(ies) available for 13-azaprostanoic acid and prostaglandin h2
| Article | Year |
|---|---|
Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Chlortetracycline; Cyclic AMP; Epoprostenol; Humans; Ion Channels; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Stimulation, Chemical; Thromboxane A2; Thromboxanes | 1985 |
Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Chlortetracycline; Epoprostenol; Humans; Indomethacin; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Stimulation, Chemical; Thromboxane A2; Thromboxanes | 1985 |
Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
Topics: Binding Sites; Blood Platelets; Cell Membrane; Fatty Acids; Humans; In Vitro Techniques; Kinetics; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxanes | 1983 |
Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Drug Interactions; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxanes | 1984 |
Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Fatty Acids; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Rabbits; Thrombosis; Thromboxane A2; Thromboxanes | 1984 |
The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles.
Topics: Adenosine Triphosphate; Arachidonic Acids; Blood Platelets; Calcium; Cell Membrane; Fatty Acids; Humans; In Vitro Techniques; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Thromboxane A2; Thromboxanes | 1983 |